Blockade of interferon induction and action by the E3L double-stranded RNA binding proteins of vaccinia virus.
about
Phospholipid scramblase 1 potentiates the antiviral activity of interferonHerpes simplex virus 1 tegument protein US11 downmodulates the RLR signaling pathway via direct interaction with RIG-I and MDA-5ICP0 prevents RNase L-independent rRNA cleavage in herpes simplex virus type 1-infected cellsEvidence that vaccinia virulence factor E3L binds to Z-DNA in vivo: Implications for development of a therapy for poxvirus infectionDiverse functions of RNase L and implications in pathologyA role for Z-DNA binding in vaccinia virus pathogenesisViral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral responseHost-range restriction of vaccinia virus E3L deletion mutant can be overcome in vitro, but not in vivo, by expression of the influenza virus NS1 proteinInterferon-inducible antiviral effectorsNegative regulation of cytoplasmic RNA-mediated antiviral signalingDimeric Structure of Pseudokinase RNase L Bound to 2-5A Reveals a Basis for Interferon-Induced Antiviral ActivityReplication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.Evasion of cellular antiviral responses by human cytomegalovirus TRS1 and IRS1Host-pathogen interactions: a biological rendez-vous of the infectious nonself and danger models?The Ebola virus VP35 protein is a suppressor of RNA silencing.Vaccinia virus E3 protein prevents the antiviral action of ISG15Viral phosphodiesterases that antagonize double-stranded RNA signaling to RNase L by degrading 2-5AInhibition of Beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3.Hepatitis A virus suppresses RIG-I-mediated IRF-3 activation to block induction of beta interferon.Mechanisms of severe acute respiratory syndrome pathogenesis and innate immunomodulation.Innate immune response of human plasmacytoid dendritic cells to poxvirus infection is subverted by vaccinia E3 via its Z-DNA/RNA binding domainRoles of vaccinia virus genes E3L and K3L and host genes PKR and RNase L during intratracheal infection of C57BL/6 mice.Alphavirus minus-strand synthesis and persistence in mouse embryo fibroblasts derived from mice lacking RNase L and protein kinase R.Stunned silence: gene expression programs in human cells infected with monkeypox or vaccinia virus.Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling.Sequestration and protection of double-stranded RNA by the betanodavirus b2 protein.Myxoma virus protein M029 is a dual function immunomodulator that inhibits PKR and also conscripts RHA/DHX9 to promote expanded host tropism and viral replicationActivation of PKR by Bunyamwera virus is independent of the viral interferon antagonist NSs.Vaccinia virus infection attenuates innate immune responses and antigen presentation by epidermal dendritic cells.The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3.The quest for an efficacious antiviral for respiratory syncytial virus.The host response to West Nile Virus infection limits viral spread through the activation of the interferon regulatory factor 3 pathway.Poxvirus immunomodulatory strategies: current perspectivesModified vaccinia virus Ankara triggers type I IFN production in murine conventional dendritic cells via a cGAS/STING-mediated cytosolic DNA-sensing pathwayPoxvirus decapping enzymes enhance virulence by preventing the accumulation of dsRNA and the induction of innate antiviral responsesFunctions of the cytoplasmic RNA sensors RIG-I and MDA-5: key regulators of innate immunity.Myxoma virus induces type I interferon production in murine plasmacytoid dendritic cells via a TLR9/MyD88-, IRF5/IRF7-, and IFNAR-dependent pathway.Comparative analysis of poxvirus orthologues of the vaccinia virus E3 protein: modulation of protein kinase R activity, cytokine responses, and virus pathogenicityVaccinia virus infection of mature dendritic cells results in activation of virus-specific naïve CD8+ T cells: a potential mechanism for direct presentation.Species specificity of protein kinase r antagonism by cytomegalovirus TRS1 genes
P2860
Q24301128-55FEDC35-6C9B-442C-AC7A-67D174097DD1Q24304261-E6650A2D-B9B8-4E70-AEA8-E38E674A591DQ24535541-31975675-B562-41E6-BF15-CD83C5311426Q24618990-8D9AF410-0842-49CE-A229-05241E598518Q24652347-F051A181-301D-42D3-A915-806204FC4D8FQ24680885-85AAB032-93C4-4FE1-9534-515D4855CADBQ24681387-3907B40B-3CE7-4D5A-B1E2-5EF7531D5C88Q27311294-A0D7B348-9175-4C82-B977-F69EC11280FCQ27486790-302BD851-0881-45A9-9EA8-1E464641B720Q27487296-9E660E7E-8122-4EB0-B940-3F03F78A65D1Q27681451-574DD724-DEF2-4835-8BB2-1B6944A87AE7Q33187731-792831DC-C119-4D66-AA25-25F8706D3B2AQ33195896-30EBCC2E-6AB1-4E87-A41E-2CEE34A92DA4Q33245068-61209AC5-4C08-4007-950F-45B39E918CFAQ33288729-5750156C-1C24-4EF1-8707-8C23928E96F5Q33349449-A71C1254-8B8C-4CF8-A68F-632AEE0222EFQ33714369-E3B83B0D-22B5-4CCC-96D3-D8FB1ED36C73Q33781480-D9A2AADC-522D-4C93-9EE1-0E6D827BCA86Q33930417-2AF2902A-EBF0-460B-8403-CC1FADE4FED9Q34014960-DBF5F4A0-8AD0-4EA1-8352-302E812D2931Q34273718-003D7A05-5812-4F22-9803-32909762D5AFQ34458051-03129ED1-360E-47EA-BAF9-93D576A1BE91Q34466906-6DBEDA8A-A1CD-44F1-BE05-5E969D26791AQ34498815-6F650FE5-CB62-46EF-9D46-7D3F1C7A02FFQ34648134-5AA528EE-2BEC-4DA7-859D-AF86D2FAC67BQ34717783-BA71CC3A-84C2-43BC-A6F7-ABE915833D15Q34819569-A2956672-B80A-4586-B5E6-3B5DA5A90B4BQ34975543-A89E473A-A5BD-42C2-9602-9186D6B9DA9CQ35101495-BE97F7F9-2986-4F86-B1AC-D11D283E4AABQ35105093-0AFCFCC7-9C09-4BD8-892E-EDDC0209B553Q35115949-7951B91C-89E5-451D-9919-894FFF0449B3Q35122610-2BFF2FD3-D44A-4FFD-926D-C08D01F4F2A8Q35125981-55CE0375-25AB-418C-92DE-38E2B057C0ABQ35151746-76BBC7C5-FB0A-4348-B5B8-AB2A88028BBAQ35177770-05F7D17F-6FBA-45FB-9C1A-3F919647DD24Q35190533-8B467C67-357A-43B8-8786-91D8759182B0Q35274869-895533F6-347C-4D17-A525-6BAA8F7C435AQ35531431-B012B967-EE04-42D6-B827-8B12D1145D66Q35774599-6E6C3766-98AC-4D80-86EF-B1657E71880DQ35826770-F6FFFC96-ECE3-43D3-840E-D8BB6B215676
P2860
Blockade of interferon induction and action by the E3L double-stranded RNA binding proteins of vaccinia virus.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Blockade of interferon inducti ...... ng proteins of vaccinia virus.
@ast
Blockade of interferon inducti ...... ng proteins of vaccinia virus.
@en
Blockade of interferon inducti ...... ng proteins of vaccinia virus.
@nl
type
label
Blockade of interferon inducti ...... ng proteins of vaccinia virus.
@ast
Blockade of interferon inducti ...... ng proteins of vaccinia virus.
@en
Blockade of interferon inducti ...... ng proteins of vaccinia virus.
@nl
prefLabel
Blockade of interferon inducti ...... ng proteins of vaccinia virus.
@ast
Blockade of interferon inducti ...... ng proteins of vaccinia virus.
@en
Blockade of interferon inducti ...... ng proteins of vaccinia virus.
@nl
P2093
P2860
P1433
P1476
Blockade of interferon inducti ...... ing proteins of vaccinia virus
@en
P2093
Bertram Jacobs
Richard C Condit
Sangeetha Vijaysri
Ying Xiang
P2860
P304
P356
10.1128/JVI.76.10.5251-5259.2002
P407
P577
2002-05-01T00:00:00Z